We are live on ! Find out more
GEA

Glen Eagle Advisors Portfolio holdings

AUM $714M
1-Year Est. Return 18.87%
This Fund
S&P 500
This Quarter Est. Return
+9.85%
1 Year Est. Return
+18.87%
3 Year Est. Return
+62.99%
5 Year Est. Return
+76.32%
10 Year Est. Return
AUM
$384M
AUM Growth
+$38.8M
Cap. Flow
+$10M
Cap. Flow %
2.61%
Top 10 Hldgs %
31.25%
Holding
1,116
New
57
Increased
224
Reduced
183
Closed
185
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UMC icon
926
United Microelectronic
UMC
$48.8B
$23 ﹤0.01%
2
NWSA icon
927
News Corp Class A
NWSA
$14.4B
$22 ﹤0.01%
1
GIGM icon
928
GigaMedia
GIGM
$14.5M
$5 ﹤0.01%
2
ADT icon
929
ADT
ADT
$5.13B
-500
Closed -$4.04K
AGZ icon
930
iShares Agency Bond ETF
AGZ
$554M
-172
Closed -$20.4K
AHCO icon
931
AdaptHealth
AHCO
$1.47B
-25
Closed -$582
AKAM icon
932
Akamai
AKAM
$17B
-20
Closed -$2.09K
ALL icon
933
Allstate
ALL
$66.6B
-200
Closed -$25.5K
ALLE icon
934
Allegion
ALLE
$13.1B
-25
Closed -$3.31K
APO icon
935
Apollo Global Management
APO
$70.2B
-165
Closed -$10.2K
APPN icon
936
Appian
APPN
$1.7B
-525
Closed -$48.6K
ARQT icon
937
Arcutis Biotherapeutics
ARQT
$3.43B
-400
Closed -$9.56K
ASA
938
ASA Gold and Precious Metals
ASA
$959M
-1,065
Closed -$20.1K
ASAN icon
939
Asana
ASAN
$1.55B
-405
Closed -$42.1K
ATNM icon
940
Actinium Pharmaceuticals
ATNM
$27.6M
-6
Closed -$53
ATR icon
941
AptarGroup
ATR
$8.36B
-65
Closed -$7.76K
AUPH icon
942
Aurinia Pharmaceuticals
AUPH
$1.98B
-600
Closed -$13.3K
AVXL icon
943
Anavex Life Sciences
AVXL
$224M
-300
Closed -$5.38K
AXGN icon
944
Axogen
AXGN
$2.15B
-375
Closed -$5.92K
AXS icon
945
AXIS Capital
AXS
$8.56B
-515
Closed -$23.7K
BDJ icon
946
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.7B
-36
Closed -$357
BE icon
947
Bloom Energy
BE
$57B
-200
Closed -$3.74K
BEAM icon
948
Beam Therapeutics
BEAM
$2.63B
-60
Closed -$5.22K
BFLY icon
949
Butterfly Network
BFLY
$1.74B
-1,075
Closed -$11.2K
BL icon
950
BlackLine
BL
$1.68B
-115
Closed -$13.6K

Similar funds

Glen Eagle Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Glen Eagle Advisors held 1,116 positions worth $384M, up 11% from $346M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Glen Eagle Advisors's Q4 2021 filing shows 57 new, 224 increased, 183 reduced and 185 closed positions. Its largest new stake was Innovator Laddered Allocation Power Buffer ETF: 165,125 shares worth $5.94M. The largest sale was Innovator Lunt Low Vol/High Beta Tactical ETF, an estimated $5.4M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

  • Glen Eagle Advisors's largest Q4 2021 buy was Innovator Laddered Allocation Power Buffer ETF: 165,125 shares worth $5.94M.
  • Glen Eagle Advisors added most to Microsoft in Q4 2021, an estimated $1.32M increase.
  • Glen Eagle Advisors's biggest Q4 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $773K.
  • Glen Eagle Advisors fully exited Innovator Lunt Low Vol/High Beta Tactical ETF in Q4 2021, selling an estimated $5.4M.
  • Glen Eagle Advisors's ten largest holdings make up 31% of its $384M portfolio in Q4 2021.
  • Glen Eagle Advisors opened 57 new positions and closed 185 in Q4 2021.
  • Glen Eagle Advisors's portfolio value rose 11% quarter-over-quarter to $384M.

Based on Glen Eagle Advisors's 13F filing for Q4 2021, filed 13 Aug 2024.